INNI
Innovaro, Inc.0.0144
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
325.65KP/E (TTM)
-Basic EPS (TTM)
-1.96Dividend Yield
0%Recent Filings
10-Q
Q3 FY2013 results
Innovaro's Q3 revenue dipped 12% y/y to $168K from $190K, yet direct costs fell sharper at 24% y/y to $135K, lifting gross margin to 20% (derived) while Intelligence & Insights Services posted $18K operating income before admin drag. Nine-month revenue held flat y/y at $414K, but $450K fixed asset impairment and $593K note receivable write-down fueled $2.4M operating loss; net matched with no taxes or material non-op items beyond $338K interest. Cash dwindled to $17K amid $713K operating outflow, total debt ~$5.1M with new $79K Asher convertible and $400K JJJ revolver; free cash flow not disclosed in the 10-Q. Liquidity strains persist. Going concern doubtful.
8-K
Innovaro raises $478K debt
Innovaro secured $78,500 via 8% convertible note from Asher Enterprises on August 15, 2013, at 42% market discount after 180 days, and a $400,000 revolving facility from JJJ Family LLLP on August 21 at 10% interest maturing August 21, 2014. Funds support general corporate needs; JJJ got warrants for 400,000 shares at $0.14. Dilution risk looms large.
10-Q
Q2 FY2013 results
Innovaro's Q2 revenue from intelligence and insights services fell 36% y/y to $94K while gross margins improved as direct costs dropped 48% y/y to $96K, yet a $450K fixed asset impairment drove operating loss to $1.1M, widening from $979K y/y mainly due to that hit. YTD revenue edged up 8% y/y to $246K, with operating loss narrowing to $1.9M from $2.0M amid cost cuts in R&D and G&A. Cash ticked up to $87K on note collections, but operating cash flow stayed negative at $412K; total debt eased to $4.9M after payments, with $2.7M corporate office mortgage extended one year. Diluted EPS loss of $0.07 aligns with 16.2M shares. Liquidity strains persist.
8-K
Annual meeting elects directors
Innovaro held its 2013 annual meeting on June 7, electing Mark Berset, John Micek III, Mark F. Radcliffe, and Asa Lanum as directors despite heavy broker non-votes of 10.9 million shares. Stockholders ratified independent accountants with 11.9 million for votes. Say-on-pay passed narrowly; most favored triennial frequency. Low turnout signals apathy.
8-K
Amends asset sale, accelerates payments
Innovaro amended its September 2012 asset sale of Pharmalicensing and related divisions to IP Tech Ex, effective August 31, 2012, accelerating payments with a $400,000 lump sum on May 29, 2013, and $300,000 due December 15, 2014 at 5% interest—slashing total consideration to $1.475M from $2M. This prompted a $489,000 Q1 2013 loss on note write-down. IP Tech Ex shares 50% of select third-party revenues through January 2014, creditable against the balance.
AACI
Armada Acquisition Corp. II
10.29-0.01
AIPG
AI TECHNOLOGY GROUP INC
2.50+0.00
AQUC
Aquaron Acquisition Corp.
12.10+0.00
ATEK
Athena Technology Acquisition C
9.02+0.00
BYNO
byNordic Acquisition Corporatio
12.15+0.00
FTII
FutureTech II Acquisition Corp.
12.02+0.00
IWSH
Wright Investors' Service Holdi
0.19+0.01
SLTN
Silverton Energy, Inc.
0.18+0.00
TCRI
TECHCOM INC.
0.17-0.00
USCTF
Roth CH Acquisition Co.
2.78+0.00